[HTML][HTML] The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification

JL Sauter, S Dacic, F Galateau-Salle… - Journal of Thoracic …, 2022 - Elsevier
Substantial changes in the 2021 WHO Classification of Tumors of the Pleura and
Pericardium since the 2015 WHO Classification include the following:(1) pleural and …

SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy

K Mardinian, JJ Adashek, GP Botta, S Kato… - Molecular cancer …, 2021 - AACR
The SWI/SNF chromatin remodeling complex, via nucleosome topology modulation,
regulates transcription. The SMARCA4 (BRG1) subunit codes for the ATPase energy engine …

[HTML][HTML] SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas

N Rekhtman, J Montecalvo, JC Chang, D Alex… - Journal of Thoracic …, 2020 - Elsevier
Introduction Highly aggressive thoracic neoplasms characterized by SMARCA4 (BRG1)
deficiency and undifferentiated round cell or rhabdoid morphology have been recently …

The epigenomics of sarcoma

BA Nacev, KB Jones, AM Intlekofer, JSE Yu… - Nature Reviews …, 2020 - nature.com
Epigenetic regulation is critical to physiological control of development, cell fate, cell
proliferation, genomic integrity and, fundamentally, transcriptional regulation. This …

SMARCA4-deficient sinonasal carcinoma: a series of 10 cases expanding the genetic spectrum of SWI/SNF-driven sinonasal malignancies

A Agaimy, D Jain, N Uddin, LM Rooper… - The American Journal …, 2020 - journals.lww.com
The molecular pathogenesis of poorly differentiated sinonasal carcinoma received
significant attention in recent years. As a consequence, several unclassified carcinomas in …

Recent updates in thoracic SMARCA4-deficient undifferentiated tumor

A Nambirajan, D Jain - Seminars in Diagnostic Pathology, 2021 - Elsevier
Germline inactivating mutations in SMARCA4 (SWI/SNF-related, matrix-associated, actin-
dependent regulator of chromatin, subfamily A, member 4) gene encoding for BRG1 …

Exceptionally rapid response to pembrolizumab in a SMARCA4‐deficient thoracic sarcoma overexpressing PD‐L1: A case report

K Takada, S Sugita, K Murase, T Kikuchi… - Thoracic …, 2019 - Wiley Online Library
SMARCA4‐deficient thoracic sarcoma (SMARCA4‐DTS) is a new clinical entity
characterized by SMARCA4 inactivation and has a dismal prognosis because of rapid …

Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor

C Henon, JY Blay, C Massard, O Mir… - Annals of …, 2019 - annalsofoncology.org
Malignant rhabdoid tumors (MRTs) are a subtype of undifferentiated soft tissue sarcoma
(STS) characterized by bi-allelic loss of function mutation in SMARCB1, a core subunit of the …

Immune-desert tumor microenvironment in thoracic SMARCA4-deficient undifferentiated tumors with limited efficacy of immune checkpoint inhibitors

J Gantzer, G Davidson, B Vokshi, N Weingertner… - The …, 2022 - academic.oup.com
Background Thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) are
aggressive neoplasms. Data linking BAF alterations with tumor microenvironment (TME) and …

SWI/SNF complex-deficient undifferentiated carcinoma of the gastrointestinal tract: clinicopathologic study of 30 cases with an emphasis on variable morphology …

B Chang, W Sheng, L Wang, X Zhu, C Tan… - The American Journal …, 2022 - journals.lww.com
Undifferentiated carcinoma of the gastrointestinal tract has variable rhabdoid features.
Expression of switch/sucrose nonfermenting (SWI/SNF) complex subunits is reportedly lost …